Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity

被引：41
作者：
Bueno, L.
De Ponti, F.
Fried, M.
Kullak-Ublick, G. A.
Kwiatek, M. A.
Pohl, D.
Quigley, E. M. M.
Tack, J.
Talley, N. J.
机构：
[1] INRA, Neurogastroenterol Unit, F-31931 Toulouse, France
[2] Univ Bologna, Dept Pharmacol, Bologna, Italy
[3] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[4] Univ Zurich Hosp, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland
[5] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[6] Univ Louvain, Dept Gastroenterol, Louvain, Belgium
[7] Mayo Clin, Coll Med, Dyspepsia Ctr, Clin Enter Neurosci Translat & Epidemiol Res Prog, Rochester, MN USA
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2007年 / 19卷
关键词：
abdominal pain; drugs; enteric flora; GI disorders; gut; sensitivity; serotonin;
D O I：
10.1111/j.1365-2982.2006.00876.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Visceral hypersensitivity is considered a key mechanism in the pathogenesis of functional gastrointestinal (GI) disorders. Targeting visceral hypersensitivity seems an attractive approach to the development of drugs for functional GI disorders. This review summarizes current knowledge on targets for the treatment of visceral hypersensitivity, and the status of current and future drug and probiotic treatment development, and the role of pharmacogenomic factors.
引用
收藏
页码：89 / 119
页数：31
相关论文
共 260 条
[1]   Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity:: a possible action through interaction with epithelial cell cytoskeleton contraction [J].
Ait-Belgnaoui, A. ;
Han, W. ;
Lamine, F. ;
Eutamene, H. ;
Fioramonti, J. ;
Bueno, L. ;
Theodorou, V. .
GUT, 2006, 55 (08) :1090-1094
[2]   Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase [J].
Ait-Belgnaoui, A ;
Bradesi, S ;
Fioramonti, J ;
Theodorou, V ;
Bueno, L .
PAIN, 2005, 113 (1-2) :141-147
[3]  
Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020
[4]  
[Anonymous], GASTROENTEROLOGY S4
[5]   Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome [J].
Atkinson, W ;
Lockhart, S ;
Whorwell, PJ ;
Keevil, B ;
Houghton, LA .
GASTROENTEROLOGY, 2006, 130 (01) :34-43
[6]  
BALSARI A, 1982, MICROBIOLOGICA, V5, P185
[7]   Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702
[8]   Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats [J].
Barreau, F ;
Cartier, C ;
Ferrier, L ;
Fioramonti, J ;
Bueno, L .
GASTROENTEROLOGY, 2004, 127 (02) :524-534
[9]   EFFECTS OF PARENTERAL DICLOFENAC SODIUM ON UPPER GASTROINTESTINAL MOTILITY AFTER FOOD IN MAN [J].
BASSOTTI, G ;
BUCANEVE, G ;
BETTI, C ;
PATOIA, L ;
BARATTA, E ;
MARESCA, V ;
PELLI, MA ;
MORELLI, A ;
DELFAVERO, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (05) :497-500
[10]   Double-blind, placebo-controlled study on effect of diclofenac sodium and indomethacin on postprandial gastric motility in man [J].
Bassotti, G ;
Bucaneve, G ;
Furno, P ;
Morelli, A ;
Del Favero, A .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (06) :1172-1176
12345678910